$AREN
Arena Group Holdings, Inc.

2015 Q3 Form 10-Q Financial Statement

#000114420415065486 Filed on November 16, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $50.00K $60.00K
YoY Change -16.67% 20.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $50.00K $60.00K
YoY Change -16.67% 20.0%
Operating Profit -$49.64K -$61.56K
YoY Change -19.36% 12.28%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$2.481K $4.597K
YoY Change -153.97% -281.13%
Pretax Income -$50.00K -$60.00K
YoY Change -16.67% 4.6%
Income Tax
% Of Pretax Income
Net Earnings -$52.12K -$56.96K
YoY Change -8.5% -0.7%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.01
Diluted Earnings Per Share -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 9.191M shares 8.868M shares
Diluted Shares Outstanding 9.191M shares 8.868M shares

Balance Sheet

Concept 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.300M $2.500M
YoY Change -8.0% -7.41%
Cash & Equivalents $341.4K $585.1K
Short-Term Investments $2.000M $1.900M
Other Short-Term Assets $0.00 $35.41K
YoY Change -100.0% -13.9%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.400M $2.523M
YoY Change -4.89% -6.33%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.400M $2.523M
Total Long-Term Assets $0.00 $0.00
Total Assets $2.400M $2.523M
YoY Change -4.89% -6.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $10.27K
YoY Change -100.0% -6.64%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $100.0K $100.0K
YoY Change 0.0% 20.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $100.0K $100.0K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $100.0K $100.0K
YoY Change 0.0% 0.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.300M $2.400M
YoY Change
Total Liabilities & Shareholders Equity $2.400M $2.500M
YoY Change -4.0% -7.19%

Cashflow Statement

Concept 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income -$52.12K -$56.96K
YoY Change -8.5% -0.7%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$60.00K -$70.00K
YoY Change -14.29% 40.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $180.0K $230.0K
YoY Change -21.74% 1050.0%
Cash From Investing Activities $180.0K $230.0K
YoY Change -21.74% 1050.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -60.00K -70.00K
Cash From Investing Activities 180.0K 230.0K
Cash From Financing Activities
Net Change In Cash 120.0K 160.0K
YoY Change -25.0% -633.33%
FREE CASH FLOW
Cash From Operating Activities -$60.00K -$70.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
83334 shares
CY2015Q2 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.15
CY2014Q4 issm Stock Issuance Date
StockIssuanceDate
2015-01-08
CY2015Q1 issm Stock Issuance Date
StockIssuanceDate
2015-04-13
CY2015Q2 issm Stock Issuance Date
StockIssuanceDate
2015-07-10
CY2015Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-55708 USD
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8868310 shares
CY2015Q3 issm Checking Account
CheckingAccount
85000 USD
CY2015Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
9200 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
102893 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1146754 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
723000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-65231 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
631259 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-200781 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
485340 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99716 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
585056 USD
issm Supplemental Gains Losses Unrealized Securities Net Of Taxes
SupplementalGainsLossesUnrealizedSecuritiesNetOfTaxes
-4762 USD
issm Supplemental Gains Losses Unrealized Securities Net Of Taxes
SupplementalGainsLossesUnrealizedSecuritiesNetOfTaxes
19553 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4762 USD
issm Stock To Be Issued During Period Value Common Stock
StockToBeIssuedDuringPeriodValueCommonStock
12500 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-168813 USD
CY2015Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
256000 USD
CY2015Q3 us-gaap Asset Backed Securities At Carrying Value
AssetBackedSecuritiesAtCarryingValue
250000 USD
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1321537 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1101281 shares
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
784815 USD
CY2015Q3 issm Available For Sale Securities Debt Maturities After One Through Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost
929334 USD
CY2015Q3 issm Available For Sale Securities Debt Maturities After Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsAmortizedCost
277828 USD
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
781679 USD
CY2015Q3 issm Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
935184 USD
CY2015Q3 issm Available For Sale Securities Debt Maturities After Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsFairValue
278141 USD
CY2014Q3 us-gaap Investment Income Net
InvestmentIncomeNet
6161 USD
CY2015Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-10463 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
49640 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
61559 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-49640 USD
CY2015Q3 us-gaap Investment Income Net
InvestmentIncomeNet
7765 USD
CY2014Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1564 USD
CY2014Q3 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
0 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-61559 USD
CY2015Q3 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
217 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2481 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4597 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-52121 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-56962 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3370 USD
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3277 USD
CY2014Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-60239 USD
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9190589 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8868310 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9190589 shares
CY2015Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
217 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
0 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3587 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3277 USD
us-gaap Share Based Compensation
ShareBasedCompensation
37500 USD
us-gaap Share Based Compensation
ShareBasedCompensation
52918 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
9792 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
3354 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-8474 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7730 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-135550 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-145919 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1221185 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
194634 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
25000 USD
CY2015Q1 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.15
CY2015Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12500 USD
CY2015Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
83334 shares
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2015Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
83334 shares
CY2015Q3 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.15
CY2015Q3 issm Stock Issuance Date
StockIssuanceDate
2015-10-12
CY2015Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12500 USD
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9199647 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8949645 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9199647 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8949645 shares
us-gaap Nature Of Operations
NatureOfOperations
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>1. Organization and Operations</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Integrated Surgical Systems, Inc. (the &#8220;Company&#8221;) was incorporated in Delaware in 1990 to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures. On June 28, 2007, the Company completed the sale of substantially all of its operating assets. After completion of the sale, the Company no longer engaged in any business activities related to its former business described above. The Company&#8217;s current operations are limited to completing a business combination or strategic alliance, when a suitable candidate is identified.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.&#160;&#160;Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2014 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
23733 USD
CY2014 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
15944 USD
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1932801 USD
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
0.17
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y2M16D
CY2015Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
200000 shares
CY2015Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
200000 shares
CY2015Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.17
CY2015Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.17
CY2015Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1321537 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1101281 shares
CY2015Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12500 USD
CY2015Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD

Files In Submission

Name View Source Status
0001144204-15-065486-index-headers.html Edgar Link pending
0001144204-15-065486-index.html Edgar Link pending
0001144204-15-065486.txt Edgar Link pending
0001144204-15-065486-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
issm-20150930.xml Edgar Link completed
issm-20150930.xsd Edgar Link pending
issm-20150930_cal.xml Edgar Link unprocessable
issm-20150930_def.xml Edgar Link unprocessable
issm-20150930_lab.xml Edgar Link unprocessable
issm-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v424085_10q.htm Edgar Link pending
v424085_ex31-1.htm Edgar Link pending
v424085_ex31-2.htm Edgar Link pending
v424085_ex32-1.htm Edgar Link pending
v424085_ex32-2.htm Edgar Link pending